Transfusion therapy: a coming-of-age treatment for patients with sickle cell disease.
Reed
W
W
Department of Hematology/Oncology, Children's Hospital Oakland, Children's Hospital Oakland Research Institute, California, USA.
Vichinsky
E P
EP
D000293:Adolescent; D000328:Adult; D000368:Aged; D000755:Anemia, Sickle Cell / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D016470:Bacteremia / Q000635:transmission; D001789:Blood Group Antigens / Q000276:immunology; D001802:Blood Substitutes / Q000627:therapeutic use; D001803:Blood Transfusion; D015913:Chelation Therapy; D002648:Child; D002675:Child, Preschool; D017707:Erythrocyte Transfusion / Q000009:adverse effects; D005260:Female; D015658:HIV Infections / Q000635:transmission; D018380:Hematopoietic Stem Cell Transplantation; D006486:Hemosiderosis / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007114:Immunization; D007223:Infant; D007231:Infant, Newborn; D008017:Life Expectancy; D008212:Lymphocyte Depletion; D008297:Male; D008875:Middle Aged; D015997:Neonatal Screening; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy; D065227:Transfusion Reaction; D014766:Viremia / Q000635:transmission
D001789:Blood Group Antigens; D001802:Blood Substitutes; D006918:Hydroxyurea